J9313 is a valid 2023 HCPCS Code that could be used to indicate Injection, moxetumomab pasudotox-tdfk, 0.01 mg for reimbursement purposes.
J9313 belongs to Medical Care Type of Service and has been in effect since Oct 01, 2019.
Inj., lumoxiti, 0.01 mg
J9313 code information
| HCPCS code: | J9313 |
| Description: | INJECTION, MOXETUMOMAB PASUDOTOX-TDFK, 0.01 MG |
| Effective Date: | Oct 01, 2019 |
| Added Date: | Oct 01, 2019 |
| Termination Date: | HCPCS J9313 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1D - CHEMOTHERAPY |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
P - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to J9313